Godavari Biorefineries Limited (BOM:544279)
284.25
-2.45 (-0.85%)
At close: Feb 13, 2026
Godavari Biorefineries Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 20,033 | 18,703 | 16,867 | 20,147 | 17,023 | 15,382 |
Other Revenue | 27.2 | 38.16 | 3.15 | - | - | - |
Revenue | 20,061 | 18,741 | 16,870 | 20,147 | 17,023 | 15,382 |
Revenue Growth (YoY) | 5.25% | 11.09% | -16.27% | 18.35% | 10.67% | 5.42% |
Cost of Revenue | 14,741 | 14,214 | 12,109 | 14,235 | 12,207 | 10,887 |
Gross Profit | 5,319 | 4,526 | 4,761 | 5,912 | 4,816 | 4,495 |
Selling, General & Admin | 1,335 | 1,254 | 1,183 | 1,166 | 994.31 | 854.92 |
Other Operating Expenses | 2,410 | 2,184 | 2,238 | 3,242 | 2,478 | 2,063 |
Operating Expenses | 4,290 | 3,949 | 4,020 | 4,909 | 3,952 | 3,390 |
Operating Income | 1,030 | 577.36 | 741.61 | 1,003 | 863.75 | 1,105 |
Interest Expense | -428.45 | -637.28 | -704.57 | -666.48 | -539.06 | -723.74 |
Interest & Investment Income | 83.63 | 83.63 | 108.71 | 25.79 | 27.31 | 32.76 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | - | - | - | - |
Other Non Operating Income (Expenses) | -38.42 | -38.42 | -20.42 | -35.03 | -26.01 | 37.53 |
EBT Excluding Unusual Items | 646.31 | -14.7 | 125.34 | 327.17 | 325.99 | 451.43 |
Gain (Loss) on Sale of Assets | -0.69 | -0.69 | -0.88 | -9.66 | -5.3 | 11.81 |
Other Unusual Items | -838.84 | -244.95 | - | - | - | - |
Pretax Income | -193.22 | -260.33 | 124.46 | 317.51 | 320.69 | 463.24 |
Income Tax Expense | 74.64 | -26.18 | 1.48 | 121.14 | 129.72 | 191.69 |
Net Income | -267.86 | -234.15 | 122.98 | 196.37 | 190.97 | 271.55 |
Net Income to Common | -267.86 | -234.15 | 122.98 | 196.37 | 190.97 | 271.55 |
Net Income Growth | - | - | -37.37% | 2.83% | -29.67% | 568.36% |
Shares Outstanding (Basic) | 51 | 46 | 42 | 42 | 42 | 42 |
Shares Outstanding (Diluted) | 51 | 46 | 42 | 42 | 42 | 42 |
Shares Change (YoY) | 17.36% | 9.35% | - | - | - | 3.09% |
EPS (Basic) | -5.24 | -5.11 | 2.93 | 4.68 | 4.55 | 6.47 |
EPS (Diluted) | -5.24 | -5.11 | 2.93 | 4.68 | 4.55 | 6.47 |
EPS Growth | - | - | -37.39% | 2.86% | -29.68% | 547.92% |
Free Cash Flow | - | -654.94 | 1,299 | -203.7 | -55.3 | 1,176 |
Free Cash Flow Per Share | - | -14.28 | 30.96 | -4.86 | -1.32 | 28.04 |
Gross Margin | 26.52% | 24.15% | 28.22% | 29.34% | 28.29% | 29.22% |
Operating Margin | 5.13% | 3.08% | 4.40% | 4.98% | 5.07% | 7.18% |
Profit Margin | -1.33% | -1.25% | 0.73% | 0.97% | 1.12% | 1.76% |
Free Cash Flow Margin | - | -3.50% | 7.70% | -1.01% | -0.33% | 7.65% |
EBITDA | 1,527 | 1,073 | 1,336 | 1,501 | 1,342 | 1,575 |
EBITDA Margin | 7.61% | 5.73% | 7.92% | 7.45% | 7.88% | 10.24% |
D&A For EBITDA | 497 | 496.13 | 594.31 | 498.4 | 477.91 | 469.75 |
EBIT | 1,030 | 577.36 | 741.61 | 1,003 | 863.75 | 1,105 |
EBIT Margin | 5.13% | 3.08% | 4.40% | 4.98% | 5.07% | 7.18% |
Effective Tax Rate | - | - | 1.19% | 38.15% | 40.45% | 41.38% |
Revenue as Reported | 20,189 | 18,869 | 17,011 | 20,231 | 17,100 | 15,464 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.